35 completed. 35 Phase 3, 3 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 35 | Completed 35 |
| Phase 2 | 3 | Completed 3 |
Follow Uveitis: new trials by email Literature Review of Uveitis trials Research Report on Uveitis
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| The Use of Two YUTIQ Versus Sham for Treatment of Chronic Non Infectious Intraocular Inflammation Affecting the Posterior Segment Yutiq 0.18 MG Drug Implant, Sham Injection - Uveitis, Uveitis, Posterior | Phase 3 | Completed | Texas Retina Associates | 10 | 2022-10-05 | 2026-10-05 |
| Suprachoroidal Triamcinolone Acetonide in Harada's Retinal Detachment Suprachoroidal Triamcinolone acetonide injection for serous retinal detachment in VKH disease - Vogt Koyanagi Harada Disease | Phase 2 / Phase 3 | Completed | Benha University | 6 | 2020-04-01 | 2021-10-07 |
| Preventing Extension of Oligoarticular Juvenile Idiopathic Arthritis JIA (Limit-JIA) Abatacept Injection, Usual Care - Juvenile Idiopathic Arthritis | Phase 3 | Completed | Duke University | 121 | 2019-10-29 | 2026-01-23 |
| Adalimumab vs. Conventional Immunosuppression for Uveitis Trial Adalimumab (ADA), Conventional immunosuppression (CON) - Uveitis | Phase 3 | Completed | JHSPH Center for Clinical Trials | 227 | 2019-09-16 | 2025-05-16 |
| Induction Therapy With Anti-TNFα vs Cyclophosphamide in Severe Behçet Disease Infliximab, Cyclophosphamide - Behcet's Disease, Vasculitis | Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 53 | 2018-05-25 | 2023-07-03 |
| Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis Interferon Alfa-2A, Cyclosporine Pill - Behçet Disease, Uveitis | Phase 3 | Completed | Peking Union Medical College Hospital | 28 | 2017-06-30 | 2021-02-23 |
| Suprachoroidal Injection of CLS-TA in Patients With Non-infectious Uveitis 4 mg CLS-TA Suprachoriodal Injection - Uveitis, Uveitis, Posterior | Phase 3 | Completed | Clearside Biomedical, Inc. | 38 | 2017-04-04 | 2021-06-23 |
| Macular Edema Ranibizumab v. Intravitreal Anti-inflammatory Therapy Trial Dexamethasone intravitreal implant 0.7 mg, Intravitreal Methotrexate 400 µg, Intravitreal Ranibizumab 0.5 mg - Uveitis, Macular Edema | Phase 3 | Completed | JHSPH Center for Clinical Trials | 194 | 2017-03-09 | 2023-07-10 |
| Safety and Efficacy of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution in Non-Infectious Anterior Uveitis Dexamethasone Phosphate Ophthalmic Solution, Prednisolone Acetate Ophthalmic (1%) - Anterior Uveitis | Phase 3 | Completed | Eyegate Pharmaceuticals, Inc. | 251 | 2016-01-16 | 2018-07-26 |
| Suprachoroidal Injection of CLS-TA in Subjects With Macular Edema Associated With Non-infectious Uveitis 4mg CLS-TA Suprachoriodal Injection, Sham Procedure - Uveitis, Uveitis, Posterior | Phase 3 | Completed | Clearside Biomedical, Inc. | 160 | 2015-11-17 | 2021-05-28 |
| A Study to Evaluate Efficacy and Safety of Infliximab in Participant With Moderate-to-Severe Refractory Intestinal Behcet's Disease Infliximab - Behcet Disease | Phase 3 | Completed | Janssen Korea, Ltd., Korea | 33 | 2015-07-22 | 2019-10-17 |
| PeriOcular and INTravitreal Corticosteroids for Uveitic Macular Edema Trial Periocular triamcinolone 40 mg, Intravitreal triamcinolone 4 mg, Dexamethasone intravitreal implant - Macular Edema, Uveitis | Phase 3 | Completed | JHSPH Center for Clinical Trials | 192 | 2015-06-16 | 2018-12-04 |
| Safety and Efficacy Study of a FAI Insert in Subjects With Chronic Non-infectious Posterior Uveitis Sham Injection, FAI Insert - Posterior Uveitis, Intermediate Uveitis | Phase 3 | Completed | EyePoint Pharmaceuticals, Inc. | 153 | 2015-06-02 | 2020-07-21 |
| A Phase 3 Randomized, Double-blind Study to Evaluate the Efficacy and Safety of Apremilast (CC-10004) in Subjects With Active Behçet's Disease Apremilast, Placebo - Behçet's Syndrome | Phase 3 | Completed | Amgen | 207 | 2014-12-30 | 2021-07-22 |
| Methotrexate and Mycophenolate Mofetil for UVEITIS Mycophenolate mofetil, Methotrexate, Prednisone - Uveitis | Phase 3 | Completed | University of California, San Francisco | 216 | 2013-08-01 | 2024-04-02 |
| Clinical Study of TA-650 in Patients With Behcet's Disease (BD) With Special Lesions TA-650 - Behcet's Disease, Behcet Syndrome | Phase 3 | Completed | Tanabe Pharma Corporation | 18 | 2012-01-01 | 2026-01-07 |
| Safety and Efficacy Study of Iontophoretic Dexamethasone Phosphate Ophthalmic Solution to Treat Non-Infectious Anterior Segment Uveitis 40 mg/mL Dexamethasone phosphate ophthalmic solution, Prednisolone Acetate (1%) Eyedrops, 100 mM sodium citrate buffer solution - Anterior Uveitis | Phase 3 | Completed | Eyegate Pharmaceuticals, Inc. | 193 | 2011-12-01 | 2013-03-29 |
| Influence of Trimethoprim-Sulfamethoxazole for the Recurrence of Ocular Toxoplasmosis Trimethoprim-Sulfamethoxazole - Ocular Toxoplasmosis | Phase 3 | Completed | University of Campinas, Brazil | 141 | 2011-10-01 | 2016-07-12 |
| Effect of Adalimumab for the Treatment of Uveitis in Juvenile Idiopathic Arthritis Anti-tumor necrosis factor alpha monoclonal antibody, placebo - Uveitis, Juvenile Arthritis | Phase 2 / Phase 3 | Completed | Assistance Publique - Hôpitaux de Paris | 34 | 2011-06-29 | 2025-09-08 |
| Study Assessing Double-masked Uveitis Treatment DE-109 44 ug, DE-109 440 ug, DE-109 880 ug - Uveitis; Posterior, Disorder | Phase 3 | Completed | Santen Inc. | 592 | 2011-05-01 | 2019-07-16 |
Showing 20 of 35. Sign in to see all of them.
Uveitis, Intermediate (11) · Panuveitis (10) · Uveitis, Posterior (10) · Behcet Syndrome (7) · Uveitis, Anterior (7) · Macular Edema (3) · Arthritis, Juvenile (2) · Arthritis (1) · Chorioretinitis (1) · Inflammation (1) · Multiple Sclerosis (1) · Retinal Vasculitis (1) · Toxoplasmosis, Ocular (1) · Uveomeningoencephalitic Syndrome (1)
Eye Diseases (35) · Uveal Diseases (35) · Panuveitis (11) · Skin and Connective Tissue Diseases (9) · Cardiovascular Diseases (7) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (7) · Genetic Diseases, Inborn (7) · Hereditary Autoinflammatory Diseases (7) · Mouth Diseases (7) · Skin Diseases (7) · Skin Diseases, Genetic (7) · Skin Diseases, Vascular (7) · Stomatognathic Diseases (7) · Uveitis, Anterior (7)
Adalimumab (4) · Methotrexate (4) · Mycophenolic Acid (4) · Prednisone (4) · Cyclosporine (3) · Dexamethasone (3) · Triamcinolone Acetonide (3) · salicylhydroxamic acid (3) · Calcium Dobesilate (2) · Fluocinolone Acetonide (2) · Infliximab (2) · Interferon alpha-2 (2) · prednisolone acetate (2) · Abatacept (1) · Azathioprine (1)
JHSPH Center for Clinical Trials (3) · Lux Biosciences, Inc. (3) · Sirion Therapeutics, Inc. (3) · AbbVie (prior sponsor, Abbott) (2) · Assistance Publique - Hôpitaux de Paris (2) · Clearside Biomedical, Inc. (2) · Eyegate Pharmaceuticals, Inc. (2) · University of California, San Francisco (2) · AbbVie (1) · Allergan (1) · Amgen (1) · Benha University (1) · Duke University (1) · EyePoint Pharmaceuticals, Inc. (1) · Heidelberg University (1)
United States (18) · India (11) · Germany (10) · France (9) · United Kingdom (8) · Canada (6) · Australia (5) · Austria (5) · Israel (5) · South Korea (4) · Brazil (3) · Greece (3) · Italy (3) · Japan (3) · Spain (3)
Eddy Anglade, M.D. (3) · Douglas A Jabs, MD, MBA (2) · John D. Sheppard, M.D. (2) · Abu Abraham, MD (1) · Ahmed Abdelshafy, MD (1) · Andy Payne (1) · Andy Payne, PhD (1) · Christoph Deuter, Dr. (1) · Douglas A Jabs, MD MBA (1) · Eveline Wu, MD (1) · Flavio Leonin Jr., MD (1) · Friederike Mackensen, MD, FEBO (1) · Ina Koetter, MD (1)
PMID 28426849, PMID 36399237, PMID 36787524, PMID 12095806, PMID 20809807, PMID 21220619, PMID 23290985, PMID 23411886, PMID 23761087, PMID 27310969, PMID 27602665, PMID 28237411, PMID 28414043, PMID 29275333, PMID 30269924, PMID 31503307, PMID 31722152, PMID 32779952, PMID 33157077, PMID 33675850, PMID 34322164, PMID 34741564, PMID 35085661, PMID 35143800, PMID 35798511, PMID 36055922, PMID 36578194, PMID 36701644, PMID 36749914, PMID 37172782, PMID 37294447, PMID 37316690, PMID 37318415, PMID 38027419, PMID 38925285, PMID 39190826
2009 (5), U10EY024527 (2), 2014 (1), U10EY021125 (1)